Nanostart Asia Pacific increases share of Singaporean cleantech company MINT
Jun 06, 2012
OTC Disclosure News Service
Frankfurt, Germany –
- Share of fund increased from 18 to28 percent
- International expansion andmarketing
Singapore – June 6, 2012 – Nanostart Asia Pacific is increasing its share in the Singaporeancompany Membrane Instruments and Technologies Pte Ltd (MINT) from 18 to 28percent. The investment in MINT will take place through the Nanostart EarlyStage Venture Fund I, which is managed by Nanostart Asia Pacific. The fundswill flow in particularto additional marketing of the Membrane Integrity Sensor and its international rollout.
The Membrane Integrity Sensor iscurrently the flagship product from MINT. It is a sensitive analysis system forcontinuous and reliable online monitoring of water quality at water treatmentfacilities. The system was developed at the Nanyang TechnologicalUniversity in Singapore and introduced to the market last year. As the firstMINT product available on the market, the sensor is alreadyin use at several facilities. The public water supplier (Public UtilitiesBoard) in Singapore is a customer.
MINT specializes in monitoring andoptimizing water treatment facilities. This allows operators to achieve significant cost savings and increase efficiency. The company develops a portfolio of sensorsto record various parameters of water treatment facilities.
Nanostart AG (OTCQX: NASRY) headquartered in the German financialcapital of Frankfurt, is a leading nanotechnology investment company, withportfolio companies spanning the globe from Silicon Valley to Singapore. Thecompany provides venture capital financing for nanotechnology companies invarious growth phases with a focus on innovation-driven industries of thefuture such as cleantech, life sciences and IT/electronics. As main shareholderof Nanostart Asia Pacific Ptd Ltd, Nanostart invests as partner of theSingapore government.
About Nanostart Asia Pacific:
Nanostart AsiaPacific Pte Ltd was established in Singapore in 2012 with the goal to explorethe growth markets of Asia. As a venture capital investment company, NanostartAsia Pacific invests in young, up-and-coming nanotechnology companies which areapproaching market launch or have innovative products already on the market. InSingapore, it invests as a partner of Singapore government via NanostartSingapore Early-Stage Venture Fund I Pte Ltd. It is a subsidiary of NanostartAG. Other shareholders of Nanostart Asia Pacific besides Nanostart AG are anumber of strategic venture capital investors out of Asia, who with theirnetwork and experience are set to facilitate Nanostart’s expansion in Asia, andthe company’s management. For more information about Nanostart Asia Pacific,please visit: www.nanostart-asia-pacific.com
Membrane Instruments and Technology Pte. Ltd. (MINT) is a spin-off from theNanyang Technological University (NTU) of Singapore, with the aim of becoming aleader in membrane instrumentation and optimization technology for the watertreatment industry. Membrane processes are set to be the next standard forwater and wastewater treatment. MINT designs and develops automated controlsystems which receive signals from nanotechnology-enabled sensors, predict theperformance of the plant and implement the correct control strategies,resulting in significant cost savings. MINT’s flagship product has beenvalidated by Singapore’s national water agency. For further informationplease visit www.mintmembranes.com.
This notice constitutes neither an offer to sell nor a solicitation of offersto purchase or subscribe to securities. There will be no public offering ofsecurities of Nanostart AG in conjunction with the existing listing of itsshares in the “Entry Standard” segment of the regulated unofficial market(Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitutea securities prospectus. Neither this notice nor the information containedwithin is intended for direct or indirect distribution within Canada, Australiaor Japan.
Dr. Hans Joachim Duerr
Head of Corporate Communications
60313 Frankfurt, Germany
phone: +49 (0)69-21 93 96 111
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.